Interestingly, altered RNA splicing by the mutant p53, through the modulation of the RNA-binding protein hnRNPK, has been shown to impact GTPase-activating proteins, leading to the activation of oncogenic RAS signaling in pancreatic cancer [59]. The gene discussed is HNRNPK; the disease is pancreatic neoplasm.